Updated Jul 16, 2026
Myles David C. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $3.34M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-15 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 35.0K | $28.99 | $1.01M |
| 2026-01-15 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 15.0K | $28.60 | $429K |
| 2026-01-15 | OLMA | Olema Pharmaceuticals, Inc. | M — Option exercise | 50.0K | $4.87 | $244K |
| 2026-01-15 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 200 | $28.49 | $6K |
| 2026-01-15 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 49.8K | $27.60 | $1.37M |
| 2026-01-15 | OLMA | Olema Pharmaceuticals, Inc. | M — Option exercise | 50.0K | $4.87 | $244K |
| 2026-01-15 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 10.0K | $28.34 | $283K |
| 2024-12-11 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 300 | $9.39 | $3K |
| 2024-12-11 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 13.3K | $8.66 | $115K |
| 2024-12-11 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 12.5K | $9.38 | $117K |
| 2024-12-11 | OLMA | Olema Pharmaceuticals, Inc. | A — Grant or award | 48.8K | $0.00 |
Myles David C. is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 8 open-market sales ($3.34M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Myles David C. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.